Pär Karlsson

646 total citations
34 papers, 400 citations indexed

About

Pär Karlsson is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, Pär Karlsson has authored 34 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Psychiatry and Mental health. Recurrent topics in Pär Karlsson's work include Maternal Mental Health During Pregnancy and Postpartum (8 papers), Pregnancy and Medication Impact (7 papers) and Attention Deficit Hyperactivity Disorder (4 papers). Pär Karlsson is often cited by papers focused on Maternal Mental Health During Pregnancy and Postpartum (8 papers), Pregnancy and Medication Impact (7 papers) and Attention Deficit Hyperactivity Disorder (4 papers). Pär Karlsson collaborates with scholars based in Sweden, United States and Norway. Pär Karlsson's co-authors include Carolyn E. Cesta, Johan Reutfors, Kari Furu, Helle Kieler, Mette Nørgaard, Krista F. Huybrechts, Brian T. Bateman, Sonia Hernández–Dı́az, Helga Zoëga and Mika Gissler and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Pär Karlsson

32 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pär Karlsson Sweden 12 131 98 69 49 35 34 400
Leila Luján‐Barroso Spain 12 76 0.6× 59 0.6× 27 0.4× 69 1.4× 24 0.7× 21 434
Anne Bénard‐Laribière France 14 63 0.5× 105 1.1× 94 1.4× 23 0.5× 58 1.7× 27 515
Laura Díaz United States 9 65 0.5× 69 0.7× 70 1.0× 29 0.6× 52 1.5× 20 281
Marie‐Noëlle Beyens France 11 123 0.9× 64 0.7× 56 0.8× 14 0.3× 75 2.1× 27 507
Ana María Linares United States 10 88 0.7× 95 1.0× 34 0.5× 26 0.5× 12 0.3× 40 388
Beom Seuk Hwang South Korea 10 66 0.5× 49 0.5× 69 1.0× 68 1.4× 17 0.5× 31 640
Taco B. M. Monster Netherlands 8 60 0.5× 102 1.0× 56 0.8× 24 0.5× 21 0.6× 14 438
Scott Stewart United States 17 67 0.5× 40 0.4× 41 0.6× 61 1.2× 65 1.9× 31 831
Sohrab Iranpour Iran 11 142 1.1× 27 0.3× 27 0.4× 49 1.0× 52 1.5× 35 509
I fan Kuo Canada 11 62 0.5× 54 0.6× 42 0.6× 25 0.5× 12 0.3× 32 328

Countries citing papers authored by Pär Karlsson

Since Specialization
Citations

This map shows the geographic impact of Pär Karlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pär Karlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pär Karlsson more than expected).

Fields of papers citing papers by Pär Karlsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pär Karlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pär Karlsson. The network helps show where Pär Karlsson may publish in the future.

Co-authorship network of co-authors of Pär Karlsson

This figure shows the co-authorship network connecting the top 25 collaborators of Pär Karlsson. A scholar is included among the top collaborators of Pär Karlsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pär Karlsson. Pär Karlsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karlsson, Pär, et al.. (2026). Factors associated with long-term hypnotics use in depression. Journal of Affective Disorders. 403. 121415–121415.
2.
Reutfors, Johan, et al.. (2025). Risk of major adverse cardiovascular events in treatment-resistant or severe depression. Journal of Affective Disorders. 386. 119419–119419.
3.
Karlsson, Pär, Anja Geldhof, Mika Gissler, et al.. (2024). Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006–2019. Pharmacoepidemiology and Drug Safety. 33(8). e5878–e5878. 1 indexed citations
4.
Giunta, Diego, et al.. (2024). Validation of diagnoses of liver disorders in users of systemic azole antifungal medication in Sweden. BMC Gastroenterology. 24(1). 21–21. 1 indexed citations
5.
Brenner, Philip, et al.. (2024). Trends in hypnotic drug use in depression 2007–2017: A Swedish population‐based study. Journal of Sleep Research. 34(1). e14267–e14267. 3 indexed citations
6.
Odsbu, Ingvild, et al.. (2023). Antibiotic use during pregnancy in Sweden: A nationwide utilization study covering 2007–2019. Acta Obstetricia Et Gynecologica Scandinavica. 103(3). 531–539. 6 indexed citations
7.
Szépligeti, Szimonetta Komjáthiné, Pär Karlsson, Kofi Asomaning, et al.. (2023). Prenatal exposure to pregabalin, birth outcomes and neurodevelopment – a population-based cohort study in four Nordic countries. Drug Safety. 46(7). 661–675. 15 indexed citations
8.
9.
Tiger, Mikael, Rikke Wesselhöeft, Pär Karlsson, et al.. (2022). Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia. Journal of Affective Disorders. 323. 292–298. 37 indexed citations
10.
Karlsson, Pär, et al.. (2022). Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns. BMC Infectious Diseases. 22(1). 492–492. 5 indexed citations
11.
Karlsson, Pär, et al.. (2021). Patterns of prescription dispensation and over-the-counter medication sales in Sweden during the COVID-19 pandemic. PLoS ONE. 16(8). e0253944–e0253944. 29 indexed citations
12.
Cesta, Carolyn E., Anders Engeland, Pär Karlsson, et al.. (2020). Incidence of Malformations After Early Pregnancy Exposure to Modafinil in Sweden and Norway. JAMA. 324(9). 895–895. 7 indexed citations
13.
Marcano, Alejandro, Pär Karlsson, Martin Gerdin Wärnberg, et al.. (2019). Income change after cruciate ligament injury — A population-based study. The Knee. 26(3). 603–611. 1 indexed citations
14.
Fortuny, Joan, Alicia Gilsenan, Miguel Cainzos‐Achirica, et al.. (2019). Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350. Drug Safety. 42(10). 1167–1177. 3 indexed citations
15.
Huybrechts, Krista F., Gabriella Bröms, Lotte Brix Christensen, et al.. (2018). Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations A Cohort Study From the International Pregnancy Safety Study Consortium. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 11 indexed citations
16.
Lexomboon, Duangjai, Pär Karlsson, Jan Adolfsson, et al.. (2017). Consumption and direct costs of dental care for patients with head and neck cancer: A 16-year cohort study. PLoS ONE. 12(8). e0182877–e0182877. 7 indexed citations
17.
Jučaitė, Aurelija, John Öhd, Alexandra Potter, et al.. (2013). A randomized, double-blind, placebo-controlled crossover study of α4β2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder. Psychopharmacology. 231(6). 1251–1265. 24 indexed citations
18.
Hannesdóttir, Kristín, Tim Ashwood, Niclas Sjögren, et al.. (2013). P2–283: Psychometric features of the ADAS‐Cog: Identifying a potential cognition endpoint for prodromal Alzheimer's disease. Alzheimer s & Dementia. 9(4S_Part_11). 2 indexed citations
19.
Wilder‐Smith, Clive H., et al.. (2005). Dose–effect comparisons of the CINOD AZD3582 and naproxen on upper gastrointestinal tract mucosal injury in healthy subjects. Scandinavian Journal of Gastroenterology. 41(3). 264–273. 16 indexed citations
20.
Jonzon, Bror, Ingvar Bjarnason, C J Hawkey, et al.. (2003). The CINOD, AZD3582, exhibits an improved gastrointestinal safety profile compared with naproxen in healthy volunteers. Inflammopharmacology. 11(4-6). 437–444. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leila Luján‐Barroso Breakdown of academic impact, for papers by Anne Bénard‐Laribière Breakdown of academic impact, for papers by Laura Díaz Breakdown of academic impact, for papers by Marie‐Noëlle Beyens Breakdown of academic impact, for papers by Ana María Linares Breakdown of academic impact, for papers by Beom Seuk Hwang Breakdown of academic impact, for papers by Taco B. M. Monster Breakdown of academic impact, for papers by Scott Stewart Breakdown of academic impact, for papers by Sohrab Iranpour Breakdown of academic impact, for papers by I fan Kuo
Rankless by CCL
2026